Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Terminal Cancer”

169 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 169 results

Not applicableUnknownNCT02022241
What this trial is testing

Repeated Injection of GnRH Agonist to Reduce Ovarian Hyperstimulation Syndrome

Who this might be right for
Infertility and at High Risk of OHSS
Chenshiling 80
Not applicableWithdrawnNCT03041571
What this trial is testing

Impact of Early Implementation of Narrative Medicine Techniques on Patient Centered Attitudes of Medical Students

Who this might be right for
Narrative MedicineChronic DiseaseTerminal Illness+6 more
University of Florida
Early research (Phase 1)Study completedNCT02259114
What this trial is testing

A Dose-Finding Study of Birabresib (MK-8628), a Small Molecule Inhibitor of the Bromodomain and Extra-Terminal (BET) Proteins, in Adults With Selected Advanced Solid Tumors (MK-8628-003)

Who this might be right for
NUT Midline CarcinomaTriple Negative Breast CancerNon-small Cell Lung Cancer With Rearranged ALK Gene/Fusion Protein or KRAS Mutation+3 more
Oncoethix GmbH, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 47
Not applicableStudy completedNCT07164352
What this trial is testing

Effect of Breathing Exercises on Pain, Dyspnea, and Function in Terminal-Stage Cancer Patients

Who this might be right for
Palliative PatientsTerminal Malignant TumorsBreathing Techniques
Atlas University 58
Testing effectiveness (Phase 2)Study completedNCT01429038
What this trial is testing

Mesenchymal Stem Cells After Renal or Liver Transplantation

Who this might be right for
Liver FailureKidney Failure
University of Liege 40
Testing effectiveness (Phase 2)Looking for participantsNCT07053462
What this trial is testing

CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk

Who this might be right for
End-Stage Renal DiseaseEnd Stage Renal Disease on DialysisEnd Stage Renal Disease With Renal Transplant+4 more
AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC 90
Not applicableUnknownNCT03866148
What this trial is testing

Obstructive Sleep Apnoea and Cardiac Arrhythmias

Who this might be right for
Obstructive Sleep ApneaCardiovascular DiseasesArrhythmia+1 more
University Hospitals Coventry and Warwickshire NHS Trust 200
Not applicableLooking for participantsNCT06615349
What this trial is testing

DigiPall; a Trial of Digital Patient Reported Outcome and Biomarker Monitoring in Palliative Care

Who this might be right for
Terminal IllnessTerminal Cancer
David Blum 382
Not applicableStudy completedNCT03677544
What this trial is testing

Predictive Factorsfor Final Pathologic Ureteral Sections

Who this might be right for
Urothelial Carcinoma
Centre Hospitalier Universitaire, Amiens 748
Testing effectiveness (Phase 2)UnknownNCT04035096
What this trial is testing

The Effectiveness of High-dose Intravenous Vitamin c With Very Low Carbohydrate Diet for Terminal Colon Cancer Patients

Who this might be right for
Colon Cancer Stage Iv
National Taiwan University Hospital 40
Testing effectiveness (Phase 2)UnknownNCT03679182
What this trial is testing

Efficacy and Safety of Olanzapine for the Treatment of Nausea and Vomiting in Palliative Cancer Care

Who this might be right for
NauseaVomitingEnd Stage Cancer
Khon Kaen University 15
Large-scale testing (Phase 3)Ended earlyNCT04269395
What this trial is testing

Assess Recurrence of Actinic Keratosis in Participants Treated With Methyl Aminolevulinate Hydrochloride Cream or Vehicle Cream Who Achieved Complete Response to Treated Lesions in Earlier Study

Who this might be right for
Keratosis, Actinic
Galderma R&D 125
Early research (Phase 1)Study completedNCT00062621
What this trial is testing

Combined Bone Marrow and Kidney Transplant for Multiple Myeloma With Kidney Failure

Who this might be right for
Kidney Failure, ChronicMultiple Myeloma
National Institute of Allergy and Infectious Diseases (NIAID) 5
Testing effectiveness (Phase 2)Study completedNCT05963386
What this trial is testing

Clinical Evaluation of 177Lu-DOTA-EB-FAPI in Patients With Various Solid Tumors

Who this might be right for
Refractory Solid Tumor
The First Affiliated Hospital of Xiamen University 28
Not applicableStudy completedNCT00904579
What this trial is testing

Cancer Risk in Organ Transplant Recipients and End-Stage Renal Disease

Who this might be right for
Immunocompromised HostOrgan TransplantationCancer
National Cancer Institute (NCI) 19,929,901
Not applicableStudy completedNCT02170168
What this trial is testing

The Orkdal Model. Collaboration Between Specialist and Community Care Within Palliative Cancer Care

Who this might be right for
Neoplasms
St. Olavs Hospital 969
Large-scale testing (Phase 3)UnknownNCT00417053
What this trial is testing

Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma Who Are Undergoing Surgery With or Without Autologous Bone Marrow or Peripheral Stem Cell Transplant

Who this might be right for
Neuroblastoma
Children's Cancer and Leukaemia Group
Very early researchStudy completedNCT00896792
What this trial is testing

Nurse Practitioner Hospice Program for Patients With Terminal Metastatic Cancer and Their Families or Caregivers

Who this might be right for
Hematopoietic/Lymphoid CancerUnspecified Adult Solid Tumor, Protocol Specific
Mayo Clinic 26
Not applicableUnknownNCT03413007
What this trial is testing

Correlation Between iXip and Final Pathology Specimen From Radical Prostatectomy: a Multicenter Prospective Trial

Who this might be right for
Prostate Cancer
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 300
Early research (Phase 1)Study completedNCT03936465
What this trial is testing

Study of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitors BMS-986158 and BMS-986378 in Pediatric Cancer

Who this might be right for
Solid Tumor, ChildhoodLymphomaBrain Tumor, Pediatric
Dana-Farber Cancer Institute 41
Next Page